Integrating public health programs and research after the malaria vaccine implementation program (MVIP):...

Area of Science:

• Global Health Ethics
• Vaccine Implementation Research
• Bioethics

Background:

• Controversy surrounds the ethical acceptability of the WHO Malaria Vaccine Implementation Program (MVIP).
• Debate exists on whether MVIP is research or a public health program, impacting ethical standard adherence.
• Concerns raised regarding informed consent and local ethical review processes.

Purpose of the Study:

• To analyze the WHO Malaria Vaccine Implementation Program (MVIP) against international ethical guidelines.
• To determine if MVIP adheres to ethical standards for human research.
• To assess the ethical implications of integrating research into public health vaccine programs.

Main Methods:

• Case analysis utilizing the 2016 CIOMS International Ethical Guidelines for Health-related Research involving Humans.
• Ethical review of the MVIP program's components and procedures.

Main Results:

• The MVIP contains a significant research component, necessitating adherence to human research ethical norms.
• Ethical requirements for informed consent and independent ethical review appear unmet.
• Potential non-compliance with the CIOMS social value requirement is a concern.

Conclusions:

• The MVIP should be treated as research, requiring full ethical review and adherence to CIOMS guidelines.
• WHO must provide MVIP protocol details, ensure informed consent, engage communities, and alter practices as needed.
• International dialogue is crucial for ethical integration of research and public health initiatives, involving target populations in program design.